The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...

The animal-health company added warnings about side effects such as seizures and paralysis to the label for Librela.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Pain medication sold at Walmart is being recalled across the country due to an error that could have "fatal" consequences, the FDA says.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

oral tablets being approved by the U.S Food and Drug Administration (FDA) last week as a first-in-class non-opioid analgesic for the treatment of acute pain in adults. “Today’s approval is an ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.